Taro Provides Results for December 31, 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
Taro Pharma (TARO) Reports Q4 EPS of $3.42
February 9, 2017 5:14 PM ESTTaro Pharma (NYSE: TARO) reported Q4 EPS of $3.42, versus $4.41 reported last year. Revenue for the quarter came in at $220.4 million, versus $258.3 thousand reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
... More